Monitor PSNL stockholder vote and regulatory filings (HSR, Form S-4). The stock will likely trade near the implied deal value, which depends on Tempus's stock price. Key risk is deal failure or extended timeline. Watch for any competing bids or shareholder litigation.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 21 $13.44entry
- T+1 · 4mo ago −7.22%α −7.10% · $12.47
- T+5 · 4mo ago −10.86%α −9.63% · $11.98
- T+20 · 3mo ago +3.50%α +0.94% · $13.91
- T+60 · 5w ago +17.93%α +13.96% · $15.85
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Personalis (PSNL) entered into a definitive merger agreement with Tempus AI (TEM) on July 20, 2026. PSNL shareholders will receive Tempus Class A common stock based on a variable exchange ratio (floor of 0.3356 if TEM ≤ $48.42, otherwise $16.25 / TEM VWAP), with Tempus having the option to pay cash for up to 50% of shares at $16.25 per share. The deal, structured as a tax-free reorganization, requires PSNL stockholder approval, HSR clearance, and other customary conditions, with a termination fee of ~$76.8 million each way. Merck, holding ~13% of PSNL, has agreed to vote in favor via a voting agreement.
Key Financial Metrics
Key Facts
- Merger consideration: Tempus Class A common stock with exchange ratio = 0.3356 if TEM ≤ $48.42, else $16.25 / TEM VWAP; Tempus may elect cash for up to 50% of shares at $16.25/share
- Merck Sharp & Dohme LLC, holding ~13% of PSNL, entered into a voting agreement to support the deal
- Termination fee of approximately $76.8 million payable by either party under specified circumstances
- Conditions include PSNL stockholder approval, HSR waiting period expiration, effectiveness of Form S-4, and tax opinion
- Outside Date initially April 20, 2027, with automatic six-month extensions up to April 20, 2028
- PSNL board unanimously approved and recommends adoption; received fairness opinions from Centerview Partners and TD Cowen
Financial Impact
Per-share consideration of $16.25 in cash (if elected) or Tempus stock with a floor of 0.3356x; total equity value implied by shares outstanding (~106.8M) is approximately $1.7B at the cash election price, but actual value is variable based on Tempus stock price
Risk Factors
- Failure to obtain PSNL stockholder approval (majority of outstanding shares required)
- Regulatory delays or antitrust challenges under HSR Act
- Tempus stock price decline reducing the value of stock consideration
- Termination by either party under specified conditions, triggering break fees
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-309101 |
| Document: d64399d8k.htm | 0001193125-26-309101 |
| Document: d64399dex101.htm | 0001193125-26-309101 |
| Document: 0001193125-26-309101-index-headers.html | 0001193125-26-309101 |
| Document: 0001193125-26-309101-index.html | 0001193125-26-309101 |
| Document: 0001193125-26-309101.txt | 0001193125-26-309101 |
Track record
29 reports on PSNL
4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +18.82% at T+60 after the Jul 20, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.16 Now $14.80 −2.34% settles Feb 12
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $15.71 Now $14.80 −5.79% settles Feb 11
- Nov 12, 20264d ago 425 Neutral 4/10 Entry $15.86 Now $14.80 −6.68% settles Feb 10
- Nov 6, 202610d ago 425 Neutral 3/10 Entry $15.95 Now $14.80 −7.21% settles Feb 5
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $15.55 Now $14.80 −4.82% settles Feb 3
- Nov 3, 202613d ago 425 Neutral 3/10 Entry $15.79 Now $14.80 −6.27% settles Feb 2
- Oct 30, 202617d ago 425 Neutral 4/10 Entry $15.76 Now $14.80 −6.09% settles Jan 29
- Oct 21, 202626d ago DEFM14A Neutral 5/10 Entry $15.82 Now $14.80 −6.45% settles Jan 20
- Oct 20, 202627d ago 425 Neutral 4/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
- Oct 20, 202627d ago 425 Neutral 5/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers